Skip to content

IDEXX Laboratories Inc Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: November 2, 2026 results vs estimates

IDEXX Laboratories Inc · E.IDXX.NASDAQ · United States
Use symbol E.IDXX.NASDAQ in our API & Excel add-in to retrieve this data ↓
575.98
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 25%
Bubble Risk LOW
Realised Volatility (20D) 25.45%

IDEXX Laboratories Inc Forecast

IDEXX Laboratories Inc short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is positive (5 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 25.4% a year, a typical one-standard-deviation range is 555.33–596.63 over a week, 533.67–618.29 over a month and 429.40–722.56 over a year. (Signals as of 1 Nov 2026.)

IDEXX Laboratories Inc Price Chart

MacroFinance.ai

IDEXX Laboratories Inc Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
IDEXX Laboratories Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
IDEXX Laboratories Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
IDEXX Laboratories Inc
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
IDEXX Laboratories Inc
P/E
38.51x
Cheap vs own history
QoQ −0.6%
YoY −32.4%
now 38.513835.12 low59.12 high
ⓘP/E As of 22 Nov 2026.See IDEXX Laboratories Inc returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
IDEXX Laboratories Inc
P/S
9.77x
Mid-range vs own history
QoQ +0.7%
YoY −30.5%
now 9.76598.79 low14.57 high
ⓘP/S As of 22 Nov 2026.See IDEXX Laboratories Inc returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
IDEXX Laboratories Inc
P/B
24.36x
Cheap vs own history
QoQ −11.1%
YoY −35.1%
now 24.358724.36 low38.91 high
ⓘP/B As of 22 Nov 2026.See IDEXX Laboratories Inc returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
IDEXX Laboratories Inc
EV/EBITDA
27.70x
Cheap vs own history
QoQ −0.7%
YoY −32.4%
now 27.700225.32 low42.46 high
ⓘEV/EBITDA As of 22 Nov 2026.See IDEXX Laboratories Inc returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
IDEXX Laboratories Inc
EV/Sales
9.93x
Mid-range vs own history
QoQ +0.3%
YoY −30.4%
now 9.93228.99 low14.79 high
ⓘEV/Sales As of 22 Nov 2026.See IDEXX Laboratories Inc returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
IDEXX Laboratories Inc
FCF Yield
2.9%
Strong vs own history
QoQ +0.8%
YoY +75.9%
now 2.86381.57 low3.13 high
ⓘFCF Yield As of 22 Nov 2026.See IDEXX Laboratories Inc returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
IDEXX Laboratories Inc
Earnings Yield
2.6%
Strong vs own history
QoQ +0.6%
YoY +48.0%
now 2.59651.69 low2.85 high
ⓘEarnings Yield As of 22 Nov 2026.See IDEXX Laboratories Inc returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
IDEXX Laboratories Inc
Market Cap
$45.5B
Mid-range vs own history
QoQ +3.1%
YoY −22.3%
now 45530.64340,029 low60,739 high
ⓘMarket Cap As of 22 Nov 2026.See IDEXX Laboratories Inc returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
IDEXX Laboratories Inc
Net Debt
$775M
Mid-range vs own history
QoQ −13.8%
YoY −14.3%
now 775.427775.43 low904.92 high
ⓘNet Debt As of 22 Nov 2026.See IDEXX Laboratories Inc returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
IDEXX Laboratories Inc
Net Debt / EBITDA
0.46x
Low vs own history
QoQ −16.6%
YoY −25.6%
now 0.46390.46 low0.62 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See IDEXX Laboratories Inc returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
IDEXX Laboratories Inc
Current Ratio
1.19x
Mid-range vs own history
QoQ +1.2%
YoY +5.6%
now 1.18651.12 low1.19 high
ⓘCurrent Ratio As of 22 Nov 2026.See IDEXX Laboratories Inc returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
IDEXX Laboratories Inc
Quick Ratio
0.88x
Mid-range vs own history
QoQ +1.1%
YoY +8.1%
now 0.87730.81 low0.88 high
ⓘQuick Ratio As of 22 Nov 2026.See IDEXX Laboratories Inc returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
IDEXX Laboratories Inc
Interest Coverage
42.17x
Strong vs own history
QoQ +12.7%
YoY +19.4%
now 42.165833.97 low42.17 high
ⓘInterest Coverage As of 22 Nov 2026.See IDEXX Laboratories Inc returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
IDEXX Laboratories Inc
Debt / Equity
0.52x
Low vs own history
QoQ −23.4%
YoY −27.0%
now 0.52050.52 low0.71 high
ⓘDebt / Equity As of 22 Nov 2026.See IDEXX Laboratories Inc returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
IDEXX Laboratories Inc
Piotroski F-Score
9
Strong vs own history
QoQ 0.0%
YoY +28.6%
now 97 low9 high
ⓘPiotroski F-Score As of 22 Nov 2026.See IDEXX Laboratories Inc returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
IDEXX Laboratories Inc
Altman Z-Score
20.31
Mid-range vs own history
QoQ +0.9%
YoY −16.6%
now 20.311718.78 low25.07 high
ⓘAltman Z-Score As of 22 Nov 2026.See IDEXX Laboratories Inc returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for IDEXX Laboratories Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

IDEXX Laboratories Inc fundamentals: income statement, balance sheet & cash flow

IDEXX Laboratories Inc reported revenue of $4.30bn and net income of $1.06bn in FY2025, the year ended 31 December 2025 — revenue up 10.4% and net income up 19.3% on the prior year. Free cash flow was $1.06bn. These figures are as reported in the filings, not restated: 35 fiscal years and 143 quarters of history, back to December 1991. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$4.30bn
+10.4%
Net income
$1.06bn
+19.3%
Gross margin
61.80%
Free cash flow
$1.06bn
+32.5%
Net debt
$897.1m
Shares short (30 Oct 2026)
2.35m
4.45 days to cover
IDEXX Laboratories Inc income statement, annual, as reported · USD millions unless stated
USD millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue4,303.73,897.53,661.03,367.33,215.4
Cost of revenue1,644.11,518.61,471.01,363.01,325.9
Gross profit2,659.62,378.92,190.02,004.31,889.4
Research & development251.2219.8191.0254.8161.0
Selling, general & admin.1,048.31,030.8901.9850.8796.4
Operating income1,360.01,128.31,097.1898.8932.0
EBITDA1,507.61,275.81,097.11,010.71,036.6
Interest expense38.331.236.038.829.4
Pre-tax income1,324.21,109.81,061.2860.0902.7
Income tax264.7222.0216.1180.9157.8
Net income1,059.5887.9845.0679.1744.8

Download IDEXX Laboratories Inc fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.IDXX.NASDAQ&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 35 fiscal years and 143 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on IDEXX Laboratories Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

IDEXX Laboratories Inc Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to IDEXX Laboratories Inc; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How IDEXX Laboratories Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how IDEXX Laboratories Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About IDEXX Laboratories Inc (United States)

IDEXX Laboratories Inc is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is IDEXX Laboratories Inc?
IDEXX Laboratories Inc is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest IDEXX Laboratories Inc price?
The latest close is 575.98 (1 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is IDEXX Laboratories Inc in an uptrend?
As of 1 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is positive (5 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is IDEXX Laboratories Inc?
20-day realised volatility is 25.4% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 7.3% over a month and 3.6% over a week.
What factors affect IDEXX Laboratories Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to IDEXX Laboratories Inc, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade IDEXX Laboratories Inc?
58 backtested tactical asset allocation strategies trade IDEXX Laboratories Inc through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are IDEXX Laboratories Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of IDEXX Laboratories Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free IDEXX Laboratories Inc historical data?
In the Free historical data section of this page: the last 10 years of IDEXX Laboratories Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free IDEXX Laboratories Inc historical data (last 10 years)

Browse or instantly download the last 10 years of IDEXX Laboratories Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.IDXX.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20676.21
2026-11-19689.65
2026-11-18698.47
2026-11-17690.24
2026-11-16700.65
2026-11-13704.23
2026-11-12698.02
2026-11-11702.59
2026-11-10696.64
2026-11-09706.65
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.